Assessment of endothelial function during the loading phase of infliximab in psoriasis: a potential predictor of its drug survival.

Momoko NakaoKouki NakamuraTakemichi FukasawaRino ShidaArisa ItoYohei IchimuraTakehiro TakahashiAya MitsuiAyumi YoshizakiSayaka ShibataMasahiro KamataMayuko ArakiRei WatanabeShinichi SatoYoshihide Asano

Published in: International journal of dermatology (2018)

The decrease in RHI values before the third infusion may serve as a predictor for the long-term unfavorable effect of infliximab on psoriatic skin lesions.

Keyphrases

ulcerative colitis
rheumatoid arthritis
low dose
ankylosing spondylitis
disease activity
soft tissue
emergency department
free survival
human health
adverse drug
atopic dermatitis
climate change
electronic health record